SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011294
Filing Date
2021-08-11
Accepted
2021-08-11 16:16:21
Documents
72
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cann-20210630x10q.htm   iXBRL 10-Q 1873723
2 EX-31.1 cann-20210630xex31d1.htm EX-31.1 11422
3 EX-31.2 cann-20210630xex31d2.htm EX-31.2 11370
4 EX-32.1 cann-20210630xex32d1.htm EX-32.1 10028
  Complete submission text file 0001558370-21-011294.txt   7871635

Data Files

Seq Description Document Type Size
5 EX-101.SCH cann-20210630.xsd EX-101.SCH 65852
6 EX-101.CAL cann-20210630_cal.xml EX-101.CAL 67357
7 EX-101.DEF cann-20210630_def.xml EX-101.DEF 263573
8 EX-101.LAB cann-20210630_lab.xml EX-101.LAB 474456
9 EX-101.PRE cann-20210630_pre.xml EX-101.PRE 431366
10 EXTRACTED XBRL INSTANCE DOCUMENT cann-20210630x10q_htm.xml XML 1373799
Mailing Address 6565 EAST EVANS AVENUE DENVER CO 80224
Business Address 6565 EAST EVANS AVENUE DENVER CO 80224 303-759-1300
GENERAL CANNABIS CORP (Filer) CIK: 0001477009 (see all company filings)

IRS No.: 208096131 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54457 | Film No.: 211163612
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences